Arima Genomics completes early access program and launches the Arima-HiC platform

5-NOV-2018 Company introduces enhanced Arima-HiC product offering to drive greater insights for chromatin conformation and genome assembly studies ARIMA GENOMICS, INC. SAN DIEGO– Arima Genomics, Inc., a biotechnology company empowering researchers to apply long-range genetic sequence and structure information towards the understanding of health, disease and species evolution, announced today the full commercial launch of... Read more

Breakthrough in Rapid Diagnostic for Antimicrobial Resistance

DNAe achieves major milestone in a novel clinical sequencing platform, successfully completing the first phase of its $51.9 million contract with US government’s BARDA London, UK and Carlsbad, CA, USA – 2 November 2018 – A rapid new diagnostic platform that harnesses the power of semiconductor DNA sequencing, promises to revolutionise the ability of physicians to... Read more

Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery

SAN DIEGO & MENLO PARK, Calif.–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and Pacific Biosciences (NASDAQ:PACB) today announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction. This price represents a premium of 71% to Pacific Biosciences’ 30 trading day volume weighted... Read more

ERS Genomics Licenses CRISPR Gene Editing Technology to DefiniGEN to Develop Human Cell Models to Support the Preclinical Development of Therapeutics

DUBLIN, Ireland, and CAMBRIDGE, UK, November 01, 2018 – ERS Genomics Limited and DefiniGEN Ltd announced today a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents. DefiniGEN will combine their best-in-class iPSC (induced Pluripotent Stem Cell) differentiation platform with CRISPR/Cas9 technology to generate a range of innovative preclinical... Read more

Agena Launches Bone Marrow Engraftment Assay For Chimerism Analysis

San Diego, CA, November 1, 2018 – Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the Chimeric ID Panel designed to reduce the time and cost of performing chimerism analysis for bone marrow engraftment monitoring studies. The SNP-based panel is designed for research use with the MassARRAY® system and is... Read more

Co-Diagnostics, Inc. and LGC Sign License Agreement for CoPrimer Technology

31 OCT 2018 Tags:  Genomics, Agriculture Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, and LGC, Biosearch Technologies, a global leader in the design, development, and manufacture of sophisticated, custom oligonucleotide-based tools and associated reagents for applied markets, announced today that they have signed an... Read more

Twist Bioscience Corporation Announces Pricing of Initial Public Offering

October 31, 2018 11:45 AM Pacific Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before... Read more

Dovetail Genomics Expands Distribution Network

-Dovetail increases global footprint with seven new distributors – SANTA CRUZ, Calif., Oct. 31, 2018 /PRNewswire/ — Dovetail Genomics™ LLC, which offers genomic products and services to address unmet needs in both human and non-human markets, expanded its growing international distribution network by signing additional partnerships in India, Australia, New Zealand, Taiwan, China, Thailand and Vietnam. Dovetails tools are used to generate accurate chromosome scale genome... Read more

Paragon Genomics Partners with Sophia Genetics for Comprehensive Genomic Solutions

–Universal SOPHiA AI Platform Now Includes Paragon Genomics’ Accurate and Sensitive CleanPlex® NGS Target Enrichment Technology for Its Rapidly-Growing Global Community of Cancer Centers– –Separately, Paragon Genomics Announces CleanPlex® UMI Research Award Program Granting Winners Free CleanPlex UMI Custom Panels that Enable Allele Frequency Detection Down to 0.1% for Liquid Biopsy and Other Applications– –Visit AMP 2018... Read more

Agilent Introduces Unique Next Generation Sequencing-based Preimplantation Genetic Testing (PGT) Solution

Agilent Introduces Unique Next Generation Sequencing-based Preimplantation Genetic Testing (PGT) Solution Agilent OnePGT solution empowers fertility specialists to attain comprehensive insights to improve the ranking of in vitro fertilized (IVF) embryos SANTA CLARA, Calif., October 31, 2018 Agilent Technologies Inc. (NYSE: A) today announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution... Read more